Related Experiment Video

Updated: Jun 13, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy

A Eckstein1, J Esser, K Mann

  • 1Department of Ophthalmology, University Duisburg-Essen, Germany. anja.eckstein@uk-essen.de

Pediatric Endocrinology Reviews : PER
|May 15, 2010
PubMed

Insights

Thyroid-stimulating hormone receptor antibodies (TRAb) are crucial for diagnosing Graves' orbitopathy (GO). Persistently high TRAb levels indicate a severe GO course and reduced hyperthyroidism remission rates, guiding treatment decisions.

Area of Science:

  • Endocrinology
  • Immunology
  • Ophthalmology

Background:

  • Graves' orbitopathy (GO) is an autoimmune condition driven by TSH-receptor antibodies (TRAb).
  • GO often co-occurs with hyperthyroidism, but can present without overt thyroid disease.
  • Accurate diagnosis and prognosis are essential for effective management.

Purpose of the Study:

  • To highlight the diagnostic and prognostic utility of TRAb in Graves' orbitopathy.
  • To emphasize the preference for second-generation TRAb assays due to improved sensitivity.
  • To correlate TRAb levels with disease severity and treatment outcomes.

Main Methods:

  • Review of diagnostic criteria and therapeutic implications of TRAb in GO.
  • Evaluation of second-generation TRAb assays for sensitivity and specificity.
  • Analysis of TRAb levels in relation to GO severity and hyperthyroidism remission.

Main Results:

  • Second-generation TRAb assays offer superior sensitivity and comparable specificity for GO diagnosis.
  • Persistently elevated TRAb levels are linked to a more severe GO course.
  • High TRAb levels correlate with lower remission rates for hyperthyroidism.

Conclusions:

  • TRAb measurement is vital for diagnosing GO, especially in non-thyroidal cases.
  • TRAb cut-off levels provide valuable prognostic information for GO and hyperthyroidism.
  • Early prognostic insights from TRAb facilitate timely treatment decisions and ophthalmosurgical planning.

More Related Videos

An Ex vivo Culture System to Study Thyroid Development08:33

An Ex vivo Culture System to Study Thyroid Development

Published on: June 6, 2014

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...